SG/CALL/BRISTOL-MYERS SQUIBB/70/0.1/20.09.24

SG/CALL/BRISTOL-MYERS SQUIBB/70/0.1/20.09.24 Share Price

DE000SQ8Z6N5

Market Closed - Deutsche Boerse AG 01:06:04 01/06/2024 am IST
0.001 ^EUR	-.--%

6 months	-97.14%
Current year	-97.22%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart BRISTOL-MYERS SQUIBB COMPANY

Chart SG/CALL/BRISTOL-MYERS SQUIBB/70/0.1/20.09.24

Latest news about BRISTOL-MYERS SQUIBB COMPANY

Pre-surgery treatment with Bristol Myers combination therapy leads to better skin cancer outcomes	05:30pm	RE
GSK blood cancer drug nearly halves risk of death in late-stage trial	05:30pm	RE
KRAZATI (adagrasib) Demonstrated Statistically Significant Improvement in Progression-Free Survival in Patients with Pretreated Locally Advanced or Metastatic KRASG12C-Mutated Non-Small Cell Lung Cancer	01/06	BU
Bristol-Myers Squibb Says Breyanzi Gets FDA Approval as CAR T Cell Therapy for Mantle Cell Lymphoma	30/05	MT

More news

Quotes 5-day view

Date	Price	Change
31/24/31	0.001	-.--%
30/24/30	0.001	-.--%
29/24/29	0.001	-.--%
28/24/28	0.001	-.--%
27/24/27	0.001	-.--%

Delayed Quote Deutsche Boerse AG

Last update May 01, 2024 at 01:06 am IST

More quotes

Static data

Product type	Warrants
Buy / Sell	CALL
Underlying	BRISTOL-MYERS SQUIBB COMPANY
Issuer	Société Générale
WKN	SQ8Z6N
ISIN	DE000SQ8Z6N5
Date issued	13/02/2023
Strike	70 $
Maturity	20/09/2024 (110 Days)
Parity	10 : 1
Emission price	1 €
Emission volume	N/A
Settlement	règlement en espèces
Currency	EUR

Technical Indicators

Highest since issue	1.1 €
Lowest since issue	0.001 €
Delta	0.03x
Omega	10.70
Premium	70.49x
Gearing	361.06x
Moneyness	0.5875
Difference Strike	28.88 $
Difference Strike %	+41.25%
Spread	0.019 €
Spread %	95.00%
Intrinsic value	0.000000

Company Profile

Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques. The United States account for 70.1% of net sales.

Sector

More about the company

Ratings for Bristol-Myers Squibb Company

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Consensus: Bristol-Myers Squibb Company

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

41.09 USD

Average target price

53.19 USD

Spread / Average Target

+29.46%

Consensus